LSD effect on kidney health in cirrhosis patients with bleeding
Part of Digestive system clinical trials.
This study looks at how a procedure called laparoscopic splenectomy and azygoportal disconnection (LSD) affects kidney function over two years in people with cirrhosis who have had bleeding from enlarged veins in the esophagus or stomach. It may help protect kidneys in the long term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cirrhosis.
- You have an enlarged spleen and low blood counts (hypersplenism).
- You have had bleeding from enlarged veins in your esophagus or stomach (variceal bleeding).
- You are between 18 and 80 years old.
- Your liver function is classified as Child-Pugh A or B (not the most severe category).
- You have no history of kidney disease or acute kidney injury.
- You are willing to participate and be followed for 24 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a surgery (LSD) in people with liver cirrhosis who have had bleeding from enlarged veins in the food pipe or stomach. It looks at whether the surgery helps improve blood fat levels over two years, which might lower future risks.
This study tests whether removing an enlarged spleen through keyhole surgery can improve kidney function in people with cirrhosis and an overactive spleen. The trial follows patients for two years to see if the surgery helps protect the kidneys.
This trial looks at whether a minimally invasive spleen surgery (with a specific vein-disconnection procedure) can better protect liver function in people with cirrhosis who have had variceal bleeding. It may help reduce stress on the liver after treatment, but you must meet several safety criteria.
This study looks at whether a type of keyhole spleen surgery plus cutting a large vein can improve immune function in people with cirrhosis. It may help reduce immune problems that can happen after complications like bleeding from varices (enlarged veins in the esophagus/stomach).
This study looks at whether removing the spleen using keyhole surgery can improve “liver reserve function” in people with cirrhosis. It may be considered for patients who have an enlarged spleen and very low platelets, but it also has several safety exclusions.
This study looks at whether removing an enlarged spleen (splenectomy) in people with cirrhosis can improve their blood fat (lipid) levels over two years. It may help those with low blood counts due to an overactive spleen.
Hear when a new Splenectomy; Status trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.